Literature DB >> 2292280

Actual usage of medical facilities by asthmatics in two French rural settings: a preliminary study.

A Taytard1, J F Tessier, M Gervais, J P Gachie, C Douet, L Kombou, J Vergeret, P Freour.   

Abstract

Until recently the medical management of asthmatic patients with respect to their socio-cultural environment had only been superficially studied. Four hundred and fifty eight adult asthmatics were identified through a two-stage questionnaire in two rural districts of south west France. The study has mainly demonstrated: 1) the large number of subjects experiencing more than one attack per week (33% in Gironde, 40% in Lot et Garonne); 2) the large number of subjects feeling disabled in their occupational and day-to-day life (52% in Gironde, 54% in Lot et Garonne); 3) the absence of a relationship between the severity of the disease and the use of medical facilities in the community. Despite the frequency of the attacks and the perceived disability, 27% of the patients felt that their asthma did not require any treatment and up to 60% did not seek medical help even during an attack; 4) the role of population density, type of dwelling and social status in the management of asthma. We conclude that under-treatment is widespread in these two rural settings and is closely related with the association of at least two of these three characteristics: 1) living in a low population density area; 2) living in an isolated dwelling; and 3) being a farm owner.

Entities:  

Mesh:

Year:  1990        PMID: 2292280

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  2 in total

1.  Health service accessibility and deaths from asthma in 401 local authority districts in England and Wales, 1988-92.

Authors:  A P Jones; G Bentham
Journal:  Thorax       Date:  1997-03       Impact factor: 9.139

2.  A district confidential enquiry into deaths due to asthma.

Authors:  N J Wareham; B D Harrison; P F Jenkins; J Nicholls; D E Stableforth
Journal:  Thorax       Date:  1993-11       Impact factor: 9.139

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.